These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 19195604)
1. Comparability of noninvasive microvolt T-wave alternans versus invasive ventricular programmed stimulation to guide implantable cardioverter-defibrillator implantation in patients at risk of sudden death. Feld GK; Clopton P J Am Coll Cardiol; 2009 Feb; 53(6):480-2. PubMed ID: 19195604 [No Abstract] [Full Text] [Related]
2. Utility of microvolt T-wave alternans to predict sudden cardiac death in patients with cardiomyopathy. Chauhan VS; Selvaraj RJ Curr Opin Cardiol; 2007 Jan; 22(1):25-32. PubMed ID: 17143041 [TBL] [Abstract][Full Text] [Related]
3. Value of microvolt T-wave alternans for predicting patients who would benefit from implantable cardioverter-defibrillator therapy. Haghjoo M; Arya A; Sadr-Ameli MA Cardiol Rev; 2006; 14(4):173-9. PubMed ID: 16788329 [TBL] [Abstract][Full Text] [Related]
4. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention. Costantini O; Hohnloser SH; Kirk MM; Lerman BB; Baker JH; Sethuraman B; Dettmer MM; Rosenbaum DS; J Am Coll Cardiol; 2009 Feb; 53(6):471-9. PubMed ID: 19195603 [TBL] [Abstract][Full Text] [Related]
13. Utility of implantable cardioverter defibrillator electrograms to estimate repolarization alternans preceding a tachyarrhythmic event. Armoundas AA; Albert CM; Cohen RJ; Mela T; J Cardiovasc Electrophysiol; 2004 May; 15(5):594-7. PubMed ID: 15149432 [TBL] [Abstract][Full Text] [Related]
14. [How to evaluate sudden cardiac death risk after myocardial infarction?]. Marijon E; Boveda S; Combes N; Albenque JP; Le Heuzey JY Ann Cardiol Angeiol (Paris); 2009 Aug; 58(4):220-5. PubMed ID: 18937927 [TBL] [Abstract][Full Text] [Related]
15. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial. Chow T; Kereiakes DJ; Onufer J; Woelfel A; Gursoy S; Peterson BJ; Brown ML; Pu W; Benditt DG; J Am Coll Cardiol; 2008 Nov; 52(20):1607-15. PubMed ID: 18992649 [TBL] [Abstract][Full Text] [Related]
16. Should microvolt T-wave alternans be utilized routinely in selecting patients for prophylactic implantable cardioverter-defibrillator insertion in the setting of ischemic heart disease? Russo AM; Marchlinski FE J Am Coll Cardiol; 2007 Jan; 49(1):59-61. PubMed ID: 17207723 [No Abstract] [Full Text] [Related]